Zobrazeno 1 - 10
of 809
pro vyhledávání: '"A L, Rapoport"'
Autor:
Mahlatse C.M. Kgokolo, Nonkululeko Z. Malinga, Helen C. Steel, Pieter W.A. Meyer, Teresa Smit, Ronald Anderson, Bernardo L. Rapoport
Publikováno v:
Translational Oncology, Vol 42, Iss , Pp 101867- (2024)
The current study compared the levels and possible associations between systemic soluble immune checkpoints (sICPs, n = 17) and a group of humoral modulators of immune suppressor cells (n = 7) in a cohort of patients with basal cell carcinoma (BCC, n
Externí odkaz:
https://doaj.org/article/c0ab158b62254a1ea1136ad9355f146d
Autor:
Maria E. Dimitriades, Andjela Markovic, Silvano R. Gefferie, Ashura Buckley, David I. Driver, Judith L. Rapoport, Margherita Nosadini, Kevin Rostasy, Stefano Sartori, Agnese Suppiej, Salome Kurth, Maurizia Franscini, Susanne Walitza, Reto Huber, Leila Tarokh, Bigna K. Bölsterli, Miriam Gerstenberg
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
BackgroundSleep disturbances are intertwined with the progression and pathophysiology of psychotic symptoms in schizophrenia. Reductions in sleep spindles, a major electrophysiological oscillation during non-rapid eye movement sleep, have been identi
Externí odkaz:
https://doaj.org/article/5f79ee1738b34155827592693f78ed07
Autor:
Bernardo L. Rapoport, Helen C. Steel, Carol A. Benn, Simon Nayler, Teresa Smit, Liezl Heyman, Annette J. Theron, Nomsa Hlatshwayo, Luyanda L.I. Kwofie, Pieter W.A. Meyer, Ronald Anderson
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Neoadjuvant chemotherapy (NAC) may alter the immune landscape of patients with early breast cancer (BC), potentially setting the scene for more effective implementation of checkpoint-targeted immunotherapy. This issue has been investigated in the cur
Externí odkaz:
https://doaj.org/article/c0d832b8aaf346e1977b95024d31c946
Autor:
Khalid El Bairi, Harry R. Haynes, Elizabeth Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner, Juliana Ribeiro de Freitas, Daniel Sur, Luis Claudio Amendola, Masoumeh Gharib, Amine Kallala, Indu Arun, Farid Azmoudeh-Ardalan, Luciana Fujimoto, Luz F. Sua, Shi-Wei Liu, Huang-Chun Lien, Pawan Kirtani, Marcelo Balancin, Hicham El Attar, Prerna Guleria, Wenxian Yang, Emad Shash, I-Chun Chen, Veronica Bautista, Jose Fernando Do Prado Moura, Bernardo L. Rapoport, Carlos Castaneda, Eunice Spengler, Gabriela Acosta-Haab, Isabel Frahm, Joselyn Sanchez, Miluska Castillo, Najat Bouchmaa, Reena R. Md Zin, Ruohong Shui, Timothy Onyuma, Wentao Yang, Zaheed Husain, Karen Willard-Gallo, An Coosemans, Edith A. Perez, Elena Provenzano, Paula Gonzalez Ericsson, Eduardo Richardet, Ravi Mehrotra, Sandra Sarancone, Anna Ehinger, David L. Rimm, John M. S. Bartlett, Giuseppe Viale, Carsten Denkert, Akira I. Hida, Christos Sotiriou, Sibylle Loibl, Stephen M. Hewitt, Sunil Badve, William Fraser Symmans, Rim S. Kim, Giancarlo Pruneri, Shom Goel, Prudence A. Francis, Gloria Inurrigarro, Rin Yamaguchi, Hernan Garcia-Rivello, Hugo Horlings, Said Afqir, Roberto Salgado, Sylvia Adams, Marleen Kok, Maria Vittoria Dieci, Stefan Michiels, Sandra Demaria, Sherene Loi, The International Immuno-Oncology Biomarker Working Group
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-17 (2021)
Abstract The advent of immune-checkpoint inhibitors (ICI) in modern oncology has significantly improved survival in several cancer settings. A subgroup of women with breast cancer (BC) has immunogenic infiltration of lymphocytes with expression of pr
Externí odkaz:
https://doaj.org/article/98d18f7227c34bcb8909cccb39302c30
Autor:
Nonkululeko Z. Malinga, Shalete C. Siwele, Helen C. Steel, Luyanda L.I. Kwofie, Pieter W.A. Meyer, Teresa Smit, Ronald Anderson, Bernardo L. Rapoport, Mahlatse C.M. Kgokolo
Publikováno v:
Translational Oncology, Vol 19, Iss , Pp 101384- (2022)
Although co-inhibitory immune checkpoint proteins are primarily involved in promoting cell-cell interactions that suppress adaptive immunity, especially tumor immunity, the soluble cell-free variants of these molecules are also detectable in the circ
Externí odkaz:
https://doaj.org/article/38c1da13674446748fab0b7151658895
Autor:
Bernardo L. Rapoport, Helen C. Steel, Nomsa Hlatshwayo, Annette J. Theron, Pieter W. A. Meyer, Simon Nayler, Carol-Ann Benn, Teresa Smit, Luyanda L. I. Kwofie, Liezl Heyman, Ronald Anderson
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Breast cancer cells exploit the up-regulation or down-regulation of immune checkpoint proteins to evade anti-tumor immune responses. To explore the possible involvement of this mechanism in promoting systemic immunosuppression, the pre-treatment leve
Externí odkaz:
https://doaj.org/article/86487d26257341118fa96a706e3a33f4
Autor:
Cindy Weinstein, Karin Jordan, Stuart Green, Saleem Khanani, Elizabeth Beckford-Brathwaite, Waldimir Vallejos, Annpey Pong, Stephen J. Noga, Bernardo L. Rapoport
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Results from a phase III, randomized, double-blind, active comparator-controlled, parallel-group trial evaluating fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting (CINV) found that a single-day, triple-
Externí odkaz:
https://doaj.org/article/175024a11a934ba19c2fa9678467f4fa
Autor:
Mahlatse C. M. Kgokolo, Katherine Anderson, Shalate C. Siwele, Helen C. Steel, Luyanda L. I. Kwofie, Mike M. Sathekge, Pieter W. A. Meyer, Bernardo L. Rapoport, Ronald Anderson
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Xeroderma Pigmentosum (XP), an autosomal recessive disorder characterized by ultraviolet radiation-induced abnormalities of DNA excision and repair pathways is associated with early development of cutaneous cancers. Intracellular oxidative stress has
Externí odkaz:
https://doaj.org/article/262f3bbc73be46c5bb3fa496f71abf77
Autor:
Alexandra Grubnik, Yastira Ramdas, Barend Van der Bergh, Simon Nayler, Carol-Ann Benn, Bernardo L. Rapoport
Publikováno v:
Case Reports in Oncological Medicine, Vol 2022 (2022)
Breast augmentation is the most common surgical procedure for women globally, with 1,795,551 cases performed in 2019. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is highly uncommon, with 733 reported cases as of January 2020.
Externí odkaz:
https://doaj.org/article/fb060ee0003d46ea9c487a1e746d1afb
Autor:
Bernardo L. Rapoport, Vickie R. Shannon, Tim Cooksley, Douglas B. Johnson, Lindsay Anderson, Ada G. Blidner, Gregory R. Tintinger, Ronald Anderson
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
The development of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment, with agents such as nivolumab, pembrolizumab, and cemiplimab targeting programmed cell death protein-1 (PD-1) and durvalumab, avelumab, and atezolizumab targe
Externí odkaz:
https://doaj.org/article/407b43c0a26f43a19b522c1f1855c2df